The World Health Organization has set a goal to reduce the global malaria cases and its mortality rate by 90% by 2030. To achieve that goal, WHO encourages the development of new malaria vaccines, antimalarial drugs, and innovative tools to kill the Anopheles mosquitoes. As part of the goal, the world’s first malaria vaccine pilot program organized by WHO has vaccinated more than one million children in Ghana, Kenya, and Malawi . The vaccine pilot program was first conducted by the Government of Malawi in 2019, followed by Ghana and Kenya.
By 2021 , more than 900,000 children were vaccinated which demonstrated the safety, feasibility, and cost-effectiveness of the malaria vaccine, RTS,SAS01 ( Figure 1 ). Figure 1 . Schematic of malaria parasite life cycle and the features of RTS,SAS01 vaccine. Following the successful vaccine pilot program, WHO expanded the use of RTS,SAS01 in…
